Switzerland-based Unitaid will fund a $33 million study at the University of Notre Dame. The grant, which will fund a five-year program determining the effectiveness of a repellent product in preventing mosquito-borne diseases, is the largest research grant awarded to a single proposal in Notre Dame’s history.
The study will have two clinical trials, one in Kenya and one in Sri Lanka. The goal of the program will be to find support to be submitted to the World Health Organization that spatial repellent can be used for public health purposes and to inform the optimal delivery and implementation of use within humanitarian response situations.
“This grant will enable research with the potential to transform the lives of millions of people around the world who suffer from mosquito-borne disease,” said Robert J. Bernhard, Notre Dame’s vice president of research. “We’re grateful for the confidence Unitaid has shown in the University of Notre Dame to lead this program.”
Connect to the full story from Notre Dame by clicking here.